What is your risk of developing PML on natalizumab? #ClinicSpeak, #MSBlog, #MSResearch
"What is a high risk of developing PML for MSers on natalizumab? Like beauty is in the eye of the beholder, risk-taking, and risk-aversion, is a personal decision that needs to be taken by an individual in consultation with their neurologist. What we do know from research is that on average neurologists are more risk-adverse than MSers. In addition, risk perception depends on a lot of factors, most of which are personal to you, and how the data is presented."
"We have developed the following aid to try and simplify the presentation of the information. You can download it by clicking on the Slideshare link on the bottom left of the embedded document. Please let us know if there is anything you don't understand on the infographic. It would also help us if you let us know how helpful you found it. Thanks."
Labels: clinic speak, ClinicSpeak, Natalizumab, PML, PML Risk, PML Risk update